These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 22537849)

  • 1. Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.
    Wang XM; Lehky TJ; Brell JM; Dorsey SG
    Cytokine; 2012 Jul; 59(1):3-9. PubMed ID: 22537849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy.
    Lees JG; Makker PG; Tonkin RS; Abdulla M; Park SB; Goldstein D; Moalem-Taylor G
    Eur J Cancer; 2017 Mar; 73():22-29. PubMed ID: 28104535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib and metformin opposingly regulate the expression of hypoxia-inducible factor alpha and the consequent development of chemotherapy-induced painful peripheral neuropathy.
    Ludman T; Melemedjian OK
    Mol Pain; 2019; 15():1744806919850043. PubMed ID: 31041875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Therapeutic Potential of Chemokines in the Treatment of Chemotherapy- Induced Peripheral Neuropathy.
    Zhou L; Ao L; Yan Y; Li W; Ye A; Hu Y; Fang W; Li Y
    Curr Drug Targets; 2020; 21(3):288-301. PubMed ID: 31490748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy.
    Fumagalli G; Monza L; Cavaletti G; Rigolio R; Meregalli C
    Front Immunol; 2020; 11():626687. PubMed ID: 33613570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy.
    Kim JH; Dougherty PM; Abdi S
    Gynecol Oncol; 2015 Mar; 136(3):453-9. PubMed ID: 25584767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy-induced peripheral neuropathy and neuropathic pain].
    Schuler U; Heller S
    Schmerz; 2017 Aug; 31(4):413-425. PubMed ID: 28293734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Toll-like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice.
    Luo X; Huh Y; Bang S; He Q; Zhang L; Matsuda M; Ji RR
    J Neurosci; 2019 Aug; 39(35):6848-6864. PubMed ID: 31270160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations.
    Hou S; Huh B; Kim HK; Kim KH; Abdi S
    Pain Physician; 2018 Nov; 21(6):571-592. PubMed ID: 30508986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.
    Bakogeorgos M; Georgoulias V
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced peripheral neuropathies in hematological malignancies.
    Jongen JL; Broijl A; Sonneveld P
    J Neurooncol; 2015 Jan; 121(2):229-37. PubMed ID: 25326770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy-induced peripheral neuropathy, based on preclinical studies in rodent models.
    Bouchenaki H; Danigo A; Sturtz F; Hajj R; Magy L; Demiot C
    Fundam Clin Pharmacol; 2021 Jun; 35(3):506-523. PubMed ID: 33107619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.
    Ma J; Kavelaars A; Dougherty PM; Heijnen CJ
    Cancer; 2018 Jun; 124(11):2289-2298. PubMed ID: 29461625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging trends in understanding chemotherapy-induced peripheral neuropathy.
    Ferrier J; Pereira V; Busserolles J; Authier N; Balayssac D
    Curr Pain Headache Rep; 2013 Oct; 17(10):364. PubMed ID: 23996720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy.
    Areti A; Yerra VG; Naidu V; Kumar A
    Redox Biol; 2014; 2():289-95. PubMed ID: 24494204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy.
    Resta F; Micheli L; Laurino A; Spinelli V; Mello T; Sartiani L; Di Cesare Mannelli L; Cerbai E; Ghelardini C; Romanelli MN; Mannaioni G; Masi A
    Neuropharmacology; 2018 Mar; 131():403-413. PubMed ID: 29339292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.
    Kanzawa-Lee GA; Knoerl R; Donohoe C; Bridges CM; Smith EML
    Semin Oncol Nurs; 2019 Jun; 35(3):253-260. PubMed ID: 31053396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Patients With and Without Painful Peripheral Neuropathy After Receiving Neurotoxic Chemotherapy: Traditional Quantitative Sensory Testing vs C-Fiber and Aδ-Fiber Selective Diode Laser Stimulation.
    Nemenov MI; Alaverdyan H; Burk C; Roles K; Frey K; Yan Y; Kazinets G; Haroutounian S
    J Pain; 2022 May; 23(5):796-809. PubMed ID: 34896646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of chemotherapy-evoked painful peripheral neuropathies.
    Authier N; Balayssac D; Marchand F; Ling B; Zangarelli A; Descoeur J; Coudore F; Bourinet E; Eschalier A
    Neurotherapeutics; 2009 Oct; 6(4):620-9. PubMed ID: 19789067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain.
    Brandolini L; d'Angelo M; Antonosante A; Allegretti M; Cimini A
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.